Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 5 | Annals of Clinical Microbiology and Antimicrobials

Fig. 5

From: Potential factors contributing to the poor antimicrobial efficacy of SAAP-148 in a rat wound infection model

Fig. 5

SAAP-148 against different bacterial loads of MRSA. The effect of 7.6 nmol SAAP-148 in PBS on different bacterial loads. a In vitro killing of 103, 105, 106 or 107 CFU MRSA by 10 µL of PBS or SAAP-148 in PBS after 30 min incubation. b Ex vivo excision wounds were inoculated with 103, 105, 106 or 107 CFU MRSA for 1 h and exposed to 10 µL of SAAP-148 in PBS or PBS for 1 h. Results are expressed as the LR. Data represent the mean of six independent experiments performed in triplicate. * indicates significant difference (*p < 0.05; **p < 0.01) as compared to the LR caused by SAAP-148 at 107 CFU MRSA

Back to article page